Advertisement
Coronavirus, US election and Brexit will weigh heavily on markets in the fourth quarter
- Apart from a winter resurgence of Covid-19 in the northern hemisphere, uncertainties about the outcome of the US presidential election, the future of UK’s departure from the European Union and US stimulus packages will make for volatility in the fourth quarter
Reading Time:3 minutes
Why you can trust SCMP
September lived up to its reputation as being a poor month for stock markets historically. The global stock market rally hit the brakes, led by sell-offs of big US technology stocks. The technology-heavy Nasdaq Composite Index entered into correction territory on September 8, after falling 10 per cent from its peak less than a week prior. More recently, the tech chills seem to have spilled into other markets, with the broad-market S&P 500 index’s brief correction on September 24 and shares sinking across Europe and Asia.
Advertisement
This is only the start. As we move into the fourth quarter, several risks are looming that will weigh on market sentiment.
The foremost risk is a significant resurgence in Covid-19 infections as the northern hemisphere moves towards the winter season. The recent increase in caseloads across Europe is of concern; the renewed fears of lockdowns were a key reason behind last week’s equity market weakness.
France and Spain are experiencing a second wave of Covid-19 infections, with case counts per million people surpassing peak levels seen during March/April this year. The United Kingdom has also witnessed a sharp rise in infections since the start of August. In the United States, there are signs of infections picking up in the last few weeks after falling through most of August and early September.
01:13
Trump calls 200,000 coronavirus death toll in US ‘a shame’
Trump calls 200,000 coronavirus death toll in US ‘a shame’
However, the large-scale national lockdowns that happened in the second quarter seem unlikely in the current circumstances. Despite rising case counts, the fatality rate seems to be thankfully lower and the hospitalisation rate is not thus far picking up as much as it did during the first wave.
Advertisement
Advertisement